Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04308330
Title Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies (NYMC195)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors New York Medical College
Age Groups: adult | child
Covered Countries USA

No variant requirements are available.